Two cases of trastuzumab deruxtecan‐induced interstitial lung disease in advanced breast cancer

Trastuzumab deruxtecan (T‐DXd) frequently induces interstitial lung disease (ILD) more than other anti‐human epidermal growth factor receptor 2 therapies. We diagnosed two cases of ILD induced by T‐DXd in patients with advanced breast cancer. The first case is that of a 57‐year‐old Japanese woman wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Gocho, Kyoko, Sato, Kenya, Iizuka, Noboru, Sunada, Kouichi, Nishiya, Shin, Hamanaka, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907559/
https://www.ncbi.nlm.nih.gov/pubmed/35280717
http://dx.doi.org/10.1002/rcr2.928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907559/
https://www.ncbi.nlm.nih.gov/pubmed/35280717
http://dx.doi.org/10.1002/rcr2.928

Ejemplares similares